Table 2.

Correlation of key Hippo genes with PFS according to tumor grade, hazard ratio, and 95% confidence interval.

Gene	Affymetrix IDs	Tumor Grade	No. of Patients		HR	95% CI	p-Value
			Low Expression	High Expression
LATS1	227772_at	I + II	64	51	1.51	0.93–3.11	0.26
		III + IV	151	363	0.85	0.69–1.05	0.13
LATS2	227013_at	I + II	50	65	0.57	0.28–1.19	0.13
		III + IV	300	164	1.57	1.29–1.92	8.1 × 10−6
MST1	213382_at	I + II	55	108	0.56	0.32–1	0.046
		III + IV	702	379	1.07	0.93–1.24	0.35
TP53	201746_at	I + II	40	123	0.48	0.27–0.87	0.014
		III + IV	582	499	0.82	0.71–0.94	0.0057
TAZ	202133_at	I + II	63	100	0.54	0.3–0.95	0.031
		III	569	512	1.15	0.99–0.32	0.06
TEF	225840_at	I + II	72	43	0.5	0.23–1.09	0.075
		III + IV	175	319	1.39	1.13–1.72	0.0022